
|Articles|November 1, 2001
NSAIDs may reduce PCa risk, prospective data show
Baltimore-Nonsteroidal anti-inflammatory drugs may reduce therisk of prostate cancer, suggests a study completed by Johns Hopkins Hospitalin Baltimore, the National Institute on Aging, and Merck Research Labs.The researchers stress that the findings are suggestive but not definitive.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
Individualizing androgen pathway therapy in mCSPC
4
BOND-003 Cohort C: Efficacy Results
5








